Healthtech Startups

AOBiome Therapeutics is a late-stage biotechnology company developing microbiome-based treatments for inflammatory skin conditions such as atopic dermatitis and pruritus. Its lead candidate, B244, uses a single strain of Ammonia Oxidizing Bacteria to moderate immune response by simultaneously down-regulating multiple inflammatory markers (IL-4, IL-5, IL-13, IL-31).

1 investor

AOK is a German public health insurance provider offering statutory health coverage with supplementary services including bonus programs, preventive health courses, and doctor programs to individual customers.

1 investor

Apaly operates an online platform that connects employers and their employees with advanced primary care providers, offering integrated healthcare services designed to reduce costs and improve quality and patient experience.

1 investor

1 investor

Apara Autism Center delivers applied behavior analysis (ABA) therapy and life skills training for children with autism in a clinical setting. The center provides comprehensive support to families through collaborative treatment plans, medical coordination, and community resources to help navigate autism diagnosis and care.

1 investor

Aparito provides Atom5, an electronic clinical outcome assessment platform that collects patient data through video assessments, patient-reported outcomes, telemedicine, wearables, and digital consent for clinical research sponsors. The platform supports multi-device data capture across iOS, Android, and web, with analytics and FDA/GDPR/HIPAA compliance for hybrid and decentralized clinical studies.

1 investor

Applied BioCode develops multiplex diagnostic testing products for infectious disease detection using proprietary barcoded magnetic bead technology. The company serves clinical and research markets with panels that detect bacterial and fungal pathogens and antimicrobial resistance markers.

1 investor

Apeiron Therapeutics is a biotech company developing small-molecule therapeutics with a focus on immuno-oncology and oncology drug discovery. The company operates across the Chinese and global healthcare markets, spanning target identification, medicinal chemistry, and clinical development.

1 investor

Aperture Bio develops technologies to translate human tumor biology in order to reduce risk in preclinical drug development.

1 investor

An online store selling injectable and oral anabolic steroids, HGH, and post-cycle therapy products directly to consumers.

1 investor

Apex Infusion is a California-based provider of infusion therapy delivered in private suites, at home, and in physician offices, along with integrated pharmacy services. It serves patients and referring healthcare providers with clinical and administrative support for infusion treatments.

1 investor

APEX is a Japanese medical device company that develops and supplies safe, innovative products and services to hospitals and customers. The company focuses on healthcare advancement while maintaining ethical business practices.

1 investor

Apiam is an Australian veterinary and animal health group operating 73 clinics and 332 veterinarians serving companion animals and livestock industries including dairy, beef, sheep, pig and poultry. The company provides veterinary care, herd health management, diagnostics, genetic services, and logistics support across Australia.

1 investor

ApiFix develops treatment solutions for pediatric scoliosis, operating as a subsidiary of OrthoPediatrics Corp. The company focuses on expanding available therapeutic options for young patients with scoliosis.

1 investor

ApoGlyx develops small-molecule aquaporin-9 inhibitors to treat severe inflammatory and metabolic diseases, including acute pancreatitis and diabetes. The company progresses its lead candidate RG210179 through clinical development and collaborates with academic institutions on drug discovery and validation.

1 investor

Improves the body's resilience to stress to help users focus, sleep, and stay energized.

1 investor

Apollo Care provides an integrated platform for pharmaceutical patient access, offering copay solutions, hub services, data warehousing, and gross-to-net analytics to improve affordability and outcomes. The company serves drug manufacturers, providers, and patients in the pharmaceutical industry.

1 investor

Apollo Sri Lanka coordinates access for patients in Sri Lanka to receive advanced medical treatment at Apollo Hospitals in India, handling consultation, medical report review, visa, and travel logistics. It focuses on services such as cancer care and proton beam therapy at internationally accredited facilities.

1 investor

apopitch is a pitch competition for startups in the pharmacy and healthcare sector, where a jury selects three finalists to present at the "München inspiriert" event organized by Alliance Healthcare Deutschland and GEHE. It is aimed at healthcare and pharmacy-focused startups in Germany.

1 investor

Apoqlar builds HoloMedicine, a spatial computing platform that combines 3D, AI, and XR technologies for use in operating rooms and hospitals. The company serves medical professionals and healthcare institutions seeking extended reality tools for surgical and clinical applications.

1 investor

AposHealth offers Apos, an FDA-cleared, foot-worn medical device personalized to each patient's biomechanics to treat knee osteoarthritis, chronic hip pain, and non-specific back pain, delivered as an at-home program supervised by a licensed physical therapist. It serves adults with chronic musculoskeletal joint pain seeking to avoid surgery or reduce medication, with access through VA benefits, commercial insurance, FSA/HSA, and UK referral pathways.

1 investor

Apostle develops cell-free DNA (cfDNA) extraction and purification kits for genomics and molecular biology laboratories. Its products are used to isolate DNA from plasma samples for downstream analysis, positioned as an alternative to established extraction kits.

1 investor

An online pharmacy that delivers prescription medications with free shipping. The service allows customers to browse products and offers in Sweden.

1 investor

Applause Pharma develops therapeutic drugs using rare earth elements as a common platform, leveraging proprietary technologies in reactive oxygen species scavenging, enzyme inhibition, and ion reactions to address unmet medical needs. The company focuses on biotech innovation with scientific evidence-based approaches to treat various diseases.

1 investor